These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1225721)

  • 1. Streptococcal preparation as an activator of host-mediated immune response: cellular immunity and alternate pathway of complement.
    Kondo M; Ikezaki M; Imanishi H; Nishigaki I; Hosokawa K
    Gan; 1975 Dec; 66(6):675-8. PubMed ID: 1225721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the properties of a streptococcal preparation OK-432 (NSC-B116209) as an immunopotentiator. I. Activation of serum complement components and peritoneal exudate cells by group A streptococcus.
    Sakai S; Ryoyama K; Koshimura S; Migita S
    Jpn J Exp Med; 1976 Apr; 46(2):123-33. PubMed ID: 778447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.
    Wild JH; Zvaifler NJ; Müller-Eberhard HJ; Wilson CB
    Clin Exp Immunol; 1976 May; 24(2):238-48. PubMed ID: 1084239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a streptococcal preparation on the complement system.
    Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement (C3) receptor-bearing lymphocyte-mediated cytotoxicity and lymphotoxin responses.
    O'Neill P; Mackler BF; Wyde P
    Cell Immunol; 1975 Nov; 20(1):33-41. PubMed ID: 1081909
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial reversal of the cellular immune defect in common variable immunodeficiency with indomethacin.
    Goodwin JS; Bankhurst AD; Murphy SA; Selinger DS; Messner RP; Williams RC
    J Clin Lab Immunol; 1978 Nov; 1(3):197-9. PubMed ID: 756469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Letter: action of levamisole on the restoration of cellular immunity in man].
    Pasquier P; Vidal M; Couture J; Niel G; Floc'h F; Werner GH
    Nouv Presse Med; 1975 Nov; 4(38):2736. PubMed ID: 1105423
    [No Abstract]   [Full Text] [Related]  

  • 9. Levamisole-mediated restoration of cellular immunity in peripheral blood lymphocytes of patients with immunodeficiency diseases.
    Lieberman R; Hsu M
    Clin Immunol Immunopathol; 1976 Jan; 5(1):142-6. PubMed ID: 1261096
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphokine production by C3b-stimulated B cells.
    Sandberg AL; Wahl SM; Mergenhagen SE
    J Immunol; 1975 Jul; 115(1):139-44. PubMed ID: 1080163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
    Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
    J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
    Edwards KM; Gewurz H; Lint TF; Mold C
    J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes.
    Wands JR; Alpert E; Isselbacher KJ
    Gastroenterology; 1975 Dec; 69(6):1286-91. PubMed ID: 1193327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative complement pathway by water-insoluble glucans of streptococcus mutans: the relation between their chemical structures and activating potencies.
    Inal S; Nagaki K; Ebisu S; Kato K; Kotani S
    J Immunol; 1976 Oct; 117(4):1256-60. PubMed ID: 977950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
    Sármay G; Ramos OF; Klein E; Kai C; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):969-74. PubMed ID: 3111862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.
    Schorlemmer HU; Bitter-Suermann D; Allison AC
    Immunology; 1977 Jun; 32(6):929-40. PubMed ID: 328387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement consumption and progression to post-streptococcal nephrotic syndrome. A report of two cases.
    Diedericks R; Coovadia HM
    S Afr Med J; 1978 Jul; 54(5):208-10. PubMed ID: 705557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal type-associated variability in alternate complement pathway activation.
    Fine DP
    Infect Immun; 1975 Oct; 12(4):772-8. PubMed ID: 329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: mechanism of resistance to complement-mediated killing.
    Fuhrman SA; Joiner KA
    J Immunol; 1989 Feb; 142(3):940-7. PubMed ID: 2643665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.